Thiazovivin
$165.00
In stock
SKU
SML10B
Thiazovivin is a potent and selective inhibitor of Rho kinase (ROCK) activity, a key player in cytoskeletal contraction and rearrangement. As ROCK inhibition occurs, human embryonic stem cell survival increases through enhanced cell-ECM attachment via E-cadherin signaling (Xu, et al.), in addition to allowing for an environment for improved human iPSCs from fibroblasts when used in combination with ALK5 inhibitor SB 431542 and MEK inhibitor PD0325901 (Lin, et al.). The addition of Thiazovivin also creates more effective conditions for the reprogramming of cord blood mononuclear cells into iPSCs (Hu, et al.).
| Molecular Name | Thiazovivin, ROCK inhibitor |
|---|---|
| Size | 10 mg |
| Form | Powder |
| Alternative Names | ROCK, RHO/ROCK |
| Chemical Name | 4-Thiazolecarboxamide, N-(phenylmethyl)-2-(4-pyrimidinylamino)- |
| Chemical Formula | C15H13N5OS |
| Molecular Weight | 311.36 |
| CAS Number | 1226056-71-8 |
| Purity | Greater than 95% by LCMS |
| Physical Appearance | White to brown (Solid) |
| Shelf-Life | Store at -20°C |
| Storage | ≥ 2 years |
Documents
Thiazovivin Technical Data Sheet
Brochure: Small Molecules for Stem Cell Research
FAQs: General Guide for Small Molecules
References and Publications
Hu, et al. 2011. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood. 117(14): 109-119.
Lin, et al. 2009. A chemical platform for improved induction of human iPSCs. Nature Methods. 6: 805-808.
Xu, et al. 2010. Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules.
Write Your Own Review